Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Know Labs has developed a proprietary non-invasive diagnostic platform using radiofrequency dielectric spectroscopy to identify and measure molecules in vivo. Its lead product—a wearable continuous glucose monitor ("KnowU")—has demonstrated proof-of-concept accuracy in distinguishing molecular concentrations in solution. Clinical testing with human subjects continues as the company prepares for FDA pivotal trials. The device aims to be the first FDA-cleared non-invasive continuous glucose monitor on the market. Peer-reviewed publication of recent studies remains pending.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Know Labs.